The pathophysiological significance of GSK3β in neurodegeneration is largely attributed to its role in tau phosphorylation and amyloid-beta (Aβ) regulation, both of which are hallmark features of Alzheimer’s disease. Here, MAPT is linked to Alzheimer disease.